Inhouse product
Indications
Urocure SR is
specifically indicated for the treatment & prophylaxis of urinary tract
infections caused by susceptible strains of Escherichia coli, Enterococci,
Staphylococcus aureus, Staphylococcus saprophyticus and certain susceptible
strains of Klebsiella and Enterobacter species.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Composition
50 mg capsule: Each capsule contains Nitrofurantoin (as
macrocrystal) USP 50 mg.
100 mg capsule: Each capsule contains Nitrofurantoin (as
macrocrystal) USP 100 mg.
Oral suspension: Each 5 ml suspension contains Nitrofurantoin
Monohydrate USP equivalent to Nitrofurantoin 25mg.
Pharmacology
Nitrofurantoin is an
antibacterial agent specific for urinary tract infections. Nitrofurantoin is
highly soluble in urine, to which it may impart a brown color. Nitrofurantoin
inactivates or alters bacterial ribosomal proteins and other macromolecules.
Nitrofurantoin has been shown to be active against the following bacteria:
Gram-Positive Aerobes Staphylococcus saprophyticus, Coagulase-negative
staphylococci (including Staphylococcus epidermidis), Enterococcus faecalis,
Staphylococcus aureus, Streptococcus agalactiae, Group D streptococci, Viridans
group streptococci. Gram-Negative Aerobes- Escherichia coli, Citrobacter
amalonaticus, Citrobacter diversus, Citrobacter freundii, Klebsiella oxytoca,
Klebsiella ozaenae.
Dosage &
Administration
Nitrofurantoin tablet
(In adults):
Nitrofurantoin capsule
(In adults):
Nitrofurantoin SR
capsule:
Nitrofurantoin
suspension: Children: 5-7 mg/kg/day in four divided doses (contraindicated
under one month of age). The average dose of Nintoin suspension for pediatric
patients are as follows-
Therapy should be
continued for one week or for at least 3 days after sterility of the urine is
obtained. For long-term suppressive therapy in children, doses as low as 1
mg/kg per 24 hours, given in a single dose or in two divided doses, may be
adequate.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
Antacids containing
Magnesium Trisilicate, when administered concomitantly with Urocure SR, reduce
both the rate and extent of absorption of Uricosuric drugs, such as Probenecid
and Sulfinpyrazone, can inhibit renal tubular secretion of Urocure SR.
Contraindications
Anuria, oliguria or
significant impairment of renal function are contraindications. This drug is
contraindicated in pregnant patients at 38-42 weeks, during labor and delivery.
Nitrofurantoin is also contraindicated in those patients with known
hypersensitivity to Nitrofurantoin.
Side Effects
The most frequent
clinical adverse events are nausea, headache, and flatulence. Other less
occurred adverse events are diarrhea, dyspepsia, abdominal pain, constipation,
emesis, dizziness and drowsiness.
Pregnancy &
Lactation
Pregnancy Category B.
There are no adequate and well-controlled studies in pregnant women. This drug
should be used during pregnancy only if clearly needed. Nitrofurantoin has been
detected in human breast milk in trace amounts. Because of the potential for
serious adverse reactions from Nitrofurantoin in nursing infants under one
month of age, a decision should be made whether to discontinue nursing or to
discontinue the drug, taking into account the importance of the drug to the
mother.
Precautions &
Warnings
If acute, sub-acute or
chronic pulmonary reactions occur, Urocure SR should be discontinued. Antacid
preparations containing magnesium trisilicate should not be taken while taking
Urocure SR.
Overdose Effects
Occasional incidents
of acute overdosage of Urocure SR have not resulted in any specific symptoms
other than vomiting. Induction of emesis is recommended.
Therapeutic Class
Systemic Urinary Anti-
infective
Storage Conditions
Do not store above
30°C. Keep away from light and out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet